Skip to content

Analysis of Changes in Blood Glucose Spinal Epidural Nerve Block with Steroids in Patients with Low Back Pain

Analysis of Changes in Blood Glucose Using a Continuous Blood Glucose Monitoring After Spinal Epidural Nerve Block with Steroids in Patients with Low Back Pain

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06818617
Enrollment
60
Registered
2025-02-10
Start date
2025-02-19
Completion date
2027-01-30
Last updated
2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glucose Level Change

Keywords

continous glucose monitering

Brief summary

This study aims to investigate the effect of different doses of dexamethasone used in epidural nerve block procedures on blood sugar levels. Patients with spinal conditions such as stenosis or disc herniation will be enrolled. Blood glucose and HbA1c levels will be measured before the procedure, and participants will use continuous glucose monitoring devices for 2-3 days before the procedure. They will be randomly assigned to one of three groups: no dexamethasone, 5mg dexamethasone, or 7.5mg dexamethasone. Blood glucose will be monitored for one week after the procedure, and follow-up will be done two weeks later to assess pain and blood sugar data. This study will help determine how steroid doses affect blood sugar, especially in elderly patients, and provide more accurate information than previous studies.

Interventions

epidural nerve block procedures for patients with spinal conditions such as stenosis or disc herniation

Sponsors

Sung Hyun Lee
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
19 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* patients need to epidural steroid injection for treating back pain * patients diagnosed with diabetes or prediabetes.

Exclusion criteria

* Patients with poorly controlled blood sugar.(HbA1c\>8.5)

Design outcomes

Primary

MeasureTime frame
Glucose changeglucose change between befor intervention and after for 7days.

Contacts

Primary ContactSung Hyun Lee
hoho4321.lee@samsung.com82-2-2001-2001

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026